Terfenadine-associated ventricular arrhythmias and QTc interval prolongation
- 12 May 1995
- journal article
- research article
- Published by Elsevier in Annals of Epidemiology
- Vol. 5 (3) , 201-209
- https://doi.org/10.1016/1047-2797(94)00039-v
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Mechanism of the cardiotoxic actions of terfenadineJAMA, 1993
- Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequencesJAMA, 1993
- Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycinClinical Pharmacology & Therapeutics, 1992
- Torsades de pointes occurring in association with terfenadine usePublished by American Medical Association (AMA) ,1991
- Torsades de pointes complicating treatment with terfenadine.BMJ, 1991
- Torsades de pointes occurring in association with terfenadine useJAMA, 1990
- Erythromycin-induced long QT syndrome: Concordance with quinidine and underlying cellular electrophysiologic mechanismThe American Journal of Medicine, 1990
- Cardiotoxic effect with convulsions in terfenadine overdose.BMJ, 1989
- Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycinThe American Journal of Cardiology, 1984
- Bioavailability of terfenadine in manBiopharmaceutics & Drug Disposition, 1981